COMMUNIQUÉS West-GlobeNewswire

Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting

05/09/2024 - 22:00

Full Data from Phase 1 Study of CK-4021586 to be Presented on September 8, 2024 SOUTH SAN FRANCISCO, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced two presentations [...]

Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets

05/09/2024 - 22:00

CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal [...]

National Toxicology Program Report Confirms Fluoride Exposure Harms Children's IQ

05/09/2024 - 18:30

LAKELAND, Fla., Sept. 05, 2024 (GLOBE NEWSWIRE) -- The National Toxicology Program’s (NTP) recent report on fluoride neurotoxicity , provides compelling scientific evidence that fluoride exposure is consistently [...]

Simulated Environment Concepts, Inc. Executes a Letter of Intent (LOI) Concerning a Prospective Merger With CMR Construction & Roofing, LLC, Recognized as One of the Leading Roofing Firms in North America

05/09/2024 - 18:30

NASHVILLE, TN, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Simulated Environment Concepts, Inc. (OTC: SMEV or Simulated) and CMR Construction & Roofing LLC (referred to as "CMR") are pleased to announce the execution of a [...]

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association

05/09/2024 - 18:12

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Halle (Saale) / Munich, Germany, September 5, 2024 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; [...]

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

05/09/2024 - 18:00

COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial [...]

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

05/09/2024 - 17:54

Key Points Immuron completes pre-IND meeting with FDA on the development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) Previous clinical trial data on IMM-529 provides [...]

New data on aprocitentan to be presented at the AHA Hypertension Scientific Sessions 2024

05/09/2024 - 17:45

Two abstracts win the prestigious AHA 2024 Paul Dudley White International Scholar Award Allschwil, Switzerland – September 5, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan, Idorsia’s [...]

BioNTX Unveils 2024 Rising Stars at the iC³® Life Science & Healthcare Innovation Summit

05/09/2024 - 17:06

IRVING, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- As Texas continues to grow as a biotech and healthcare innovative hub, BioNTX is honored to announce the 2024 Rising Stars, a select group of pioneering companies that [...]

Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results

05/09/2024 - 16:52

Ingelheim, Germany and Basel, Switzerland, September 5, 2024 – Boehringer Ingelheim and CDR-Life today announce positive results from the Phase I evaluation of BI 771716 ( Study Record | ClinicalTrials.gov ), an [...]

Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

05/09/2024 - 16:35

PRINCETON, N.J., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine that [...]

Acentra Health Awarded a $298 Million Contract Renewal from the Centers for Medicare & Medicaid Services to Continue Improving Care Quality for Medicare Beneficiaries

05/09/2024 - 15:53

The company has established the largest geographic footprint of any CMS-contracted partner for beneficiary and family centered care-quality improvement services, serving Medicare enrollees across 29 states MCLEAN, Va., [...]

Pheton Holdings Ltd Announces Pricing of Initial Public Offering

05/09/2024 - 15:31

BEIJING, China, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company” or “Pheton”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products [...]

Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference

05/09/2024 - 15:10

CHICAGO and FORT WORTH, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for [...]

New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery

05/09/2024 - 15:00

YARDLEY, Pa., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the peer-review [...]

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering

05/09/2024 - 15:00

CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the pricing of a public offering of 14,724,058 shares of common stock, par value $0.001 per [...]

Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment

05/09/2024 - 15:00

Meeting showcases the potential role of Nexalin's neurostimulation technology in revolutionizing opioid treatment through virtual care solutions HOUSTON, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. ( [...]

Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease

05/09/2024 - 15:00

GAITHERSBURG, Md., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals, a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation [...]

Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors

05/09/2024 - 15:00

TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain [...]